TUZIL, Jan, Barbora FILKOVA PILNACKOVA, Torquil WATT, Jan JISKRA, Marcela KOUDELKOVÁ, Eva NOVOTNA, Klara TUZILOVA, Tomáš DOLEŽAL a Jana BARTAKOVA. The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39. Value in health. NEW YORK: ELSEVIER SCIENCE INC, 2023, roč. 26, č. 7, s. 1085-1097. ISSN 1098-3015. Dostupné z: https://dx.doi.org/10.1016/j.jval.2023.02.015.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název The Impact of Subclinical Hypothyroidism on the Quality of Life During Pregnancy: Mapping 5-Level Version of EQ-5D and ThyPRO-39
Autoři TUZIL, Jan (203 Česká republika, garant), Barbora FILKOVA PILNACKOVA (203 Česká republika), Torquil WATT, Jan JISKRA (203 Česká republika), Marcela KOUDELKOVÁ (203 Česká republika, domácí), Eva NOVOTNA (203 Česká republika), Klara TUZILOVA (203 Česká republika), Tomáš DOLEŽAL (203 Česká republika, domácí) a Jana BARTAKOVA (203 Česká republika).
Vydání Value in health, NEW YORK, ELSEVIER SCIENCE INC, 2023, 1098-3015.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.500 v roce 2022
Kód RIV RIV/00216224:14110/23:00133293
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1016/j.jval.2023.02.015
UT WoS 001029792800001
Klíčová slova anglicky EQ-5D; hypothyroidism; pregnancy; quality of life; ThyPRO-39
Štítky 14110516, 14119612, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 29. 1. 2024 12:57.
Anotace
Objectives: To describe how subclinical hypothyroidism (SubHypo) influences the quality of life (QoL) during pregnancy. Methods: In primary data collection (NCT04167423), thyroid stimulating hormone (TSH), free thyroxine (FT4), thyroid peroxidase antibodies, generic quality of life (QoL; 5-level version of EQ-5D [EQ-5D-5L]), and disease-specific QoL (ThyPRO-39) were measured among pregnant women. SubHypo during each trimester was defined according to the 2014 European Thyroid Association guidelines (TSH . 2.5, 3.0, and 3.5 IU/L, respectively; with normal FT4). Path analysis described relationships and tested mediation. Linear ordinary least squares, beta, tobit, and two-part regressions were used to map ThyPRO-39 and EQ-5D-5L. Alternative SubHypo definition was tested in sensitivity analysis. Results: A total of 253 women at 14 sites (31 & PLUSMN; 5 years old, 15 & PLUSMN; 6 weeks pregnant) completed the questionnaires. Sixty-one (26%) had SubHypo and differed from 174 (74%) euthyroid women in smoking history (61% vs 41%), primiparity (62% vs 43%) and TSH level (4.1 & PLUSMN; 1.4 vs 1.5 & PLUSMN; 0.7 mIU/L, P < .001). EQ-5D-5L utility in SubHypo (0.89 & PLUSMN; 0.12) was lower than that in euthyroid (0.92 & PLUSMN; 0.11; P = .028) even after adjustment (difference 20.04, P = .033), whereas ocular (P = .001, ThyPRO-39), cognitive symptoms (P = .043), anxiety (P < .0001), and the composite score were higher. The impact of SubHypo on utility was mediated by anxiety. Results were confirmed by sensitivity analysis. Final mapping equation (ordinary least squares) includes goiter symptoms, anxiety, upset stomach, composite score (ThyPRO-39), FT4 levels, and week of pregnancy (determination coefficient 0.36). Conclusion: This is the first QoL mapping of SubHypo during pregnancy and the first evidence that SubHypo is associated with a negative impact on QoL. The effect is mediated by anxiety. EQ-5D-5L utilities can be generated based on ThyPRO-39 scores collected in pregnant euthyroid and patients with SubHypo.
VytisknoutZobrazeno: 29. 7. 2024 01:28